1. In women with MS-AFP ≥ 2.5 MoM, higher risks of SGA (OR: 1.90, 95% CI: 1.34-2.69), preterm birth (OR: 2.53, 95% CI: 1.65-3.88), and preeclampsia (OR: 3.05, 95% CI: 1.71-5.43).2. In women with MS-AFP ≥ 2.5 MoM, lower neonatal birth weights (p = 0.000) and earlier gestational weeks at delivery (p = 0.004) were indicated. This evidence concerns the gene AFP and preeclampsia.